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 Introduction 
 The pathophysiological process of Alzheimer’s disease 
(AD) is multifactorial but has a genetically heterogeneous 
background as well. This is evidenced by the widely con-
firmed genetic risk genes  APP,  PSEN1, PSEN2, and  APOE . 
However, genomewide linkage studies had located multi-
ple genomic regions that might harbor potentially suscep-
tible genes. Among these candidate regions, the chromo-
some 12p13 locus has recently attracted much attention. 
In fact, the initial genomic screen described linkage of 
late-onset AD to the centromeric region markers of chro-
mosome 12, supported by familial associations  [1, 2] . Var-
ious succeeding replication studies then provided addi-
tional evidence linking AD with chromosome 12  [3–5] ; in 
particular, subsequent fine mapping of the chromosome 
12 linkage locus and conditional linkage analysis focusing 
on heterogeneity both found that the linkage to chromo-
some 12 was independent of the  APOE   4 allele  [6] . Fur-
ther association analyses have now pointed to a smaller 
region of the chromosome 12p13 locus, thus narrowing 
down late-onset AD association to single genes as shown 
by the two recent studies. Of note, a large-scale single nu-
cleotide polymorphisms (SNP)-based association study by 
Li et al.  [7] found strong associations with the  GAPD gene, 
as well as with other genes  ( CNAP1 ,  PKP2P1 ) in this re-
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 Abstract 
 Recent linkage and association studies have implicated the 
chromosome 12p13 locus as possibly harboring genetic vari-
ants predisposed to Alzheimer’s disease (AD). We attempted 
to replicate this association in a Chinese data set comprised 
of 256 AD cases and 264 age-matched normal controls. A 
total of 14 single nucleotide polymorphisms (SNPs) were ex-
amined. Single marker association revealed the two SNPs in 
 NCAPD2  (rs7311174 and rs2072374) as showing nominal sig-
nificant p values (p = 0.0491 and 0.0116, respectively). Hap-
lotype analysis found LD block one to be significantly associ-
ated with AD (global p = 0.0250). Haplotypes CGGATG and 
CAGTCG were also significantly associated with AD (p = 
0.0498 and p = 0.0482, respectively). These genetic analyses 
provide evidence that the chromosome 12p13 locus is asso-
ciated with AD in Chinese.  Copyright © 2009 S. Karger AG, Basel 
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gion. Consequently in 2008, Lee et al.  [8]  finely mapped 
this region, revealing more gene association with late-on-
set AD  [7, 8] . In an effort to replicate this finding, we se-
lected the same panel of polymorphism markers and con-
ducted genotyping in our Chinese data set. 
 Materials and Methods  
 The research protocol was approved by the Institutional Re-
view Board (IRB) of the University of Hong Kong and the Hospi-
tal Authority Hong Kong West Cluster (HKU/HA HKW IRB). 
Informed consent was obtained from all individuals participating 
in this study. A total of 256 Chinese sporadic AD patients and 264 
normal subjects were recruited. Demented subjects were recruit-
ed consecutively from the Memory Clinic of Queen Mary Hospi-
tal of the University of Hong Kong  [9–11] . Normal control subjects 
were recruited from community elderly social centers. All sub-
jects underwent a standardized, semistructured and detailed cog-
nitive assessment protocol for cognitive impairment and demen-
tia. History of memory impairment and cognitive functioning 
were obtained from both the subjects and informants (either fam-
ily members or caregivers). Every subject also received a full phys-
ical and neurological examination. Standardized cognitive as-
sessment tools including the Chinese versions of Mini-Mental 
State Examination (MMSE), Alzheimer’s Disease Assessment 
Scale-Cognitive Subscale and Delayed 10-Word Recall Test 
(DWRT) were administered to all subjects. The DWRT has been 
reported previously. It consists of 10 Chinese words. Every subject 
was given three immediate registration and immediate recall tri-
als, which were followed by a delayed free recall trial after 10 min. 
The number of correct freely recalled words was the DWRT score. 
Cutoff scores of 26 or above and 6 or above were used for the Chi-
nese MMSE score and DWRT, respectively. All subjects were rat-
ed by a single rater (L.W.C.) with the Clinical Dementia Rating 
Scale (CDR). In the CDR, CDR 0 would mean no cognitive im-
pairment (i.e. normal nondemented persons). For AD patients, 
the CDR would depend on the stage of the dementia illness and 
range from CDR 0.5 to 3.0 (i.e. 0.5 very mild, 1.0 mild, 2.0 moder-
ate, 3.0 severe or advanced). All subjects were evaluated by a stan-
dardized battery of laboratory investigations including thyroid 
function tests (serum TSH), serum vitamin B 12 and folate levels, 
and red blood cell folate level. CT brain scans were done for sub-
jects with AD but not for the normal subjects. All normal subjects 
had CDR ratings of CDR 0 and had no evidence of any neurolog-
ical disease, while AD subjects were diagnosed in accordance to 
the NINCDS/ADRDA criteria for probable AD. Subjects with 
non-AD types of dementia, secondary causes of dementia and fa-
milial AD were excluded from the present study  [12] . Family his-
tory of AD and dementia in first-degree relatives of subjects (fa-
ther, mother, brother and/or sister) was reported by family mem-
bers (spouse, children or sibling) of subjects during the face-to-face 
interviews. The AD patients’ mean age at the time of examination 
was 79.0  8 7.2 years (ranging from 65 to 97 years), while the con-
trols’ mean age was 72.1  8 5.6 years (ranging from 65 to 90 years). 
As for the disease group, 72.3% were females and 27.7% were 
males, whereas in the control group, 71.7% were females and 
28.3% were males.
 Genetic Analyses 
 After obtaining the participants’ fully informed consent, 
blood samples (10 ml) and answers to questionnaires of environ-
mental risk factors were collected. Genomic DNA samples were 
then isolated from the buffy coat leukocytes, with DNA quality 
and quantity measured by a DNA fluorometer. Meanwhile,  ApoE 
genotypes were determined by a modified method  [13, 14] .
 PCR Amplification/Genotyping 
 The Sequenom  platform was used for genotyping, while the 
Mass ARRAY AssayDesign software (Sequenom) was employed 
to design amplification and allele-specific extension primers for 
uniplex or multiplexed assays. The PCR reactions were set up in 
384-well plates at 6 ml total volume per reaction, the reaction mix 
containing 5 ng genomic DNA, 0.3 pmol each of specific forward 
and reverse primers, 200 m M each of dNTP, 3.25 m M MgCl 2 , and 
0.2 unit of HotStarTaq polymerase (5 U/ml, Qiagen, Valencia, Cal-
if., USA). The PCR condition was controlled at 95 ° C for 15 min, 
with 45 cycles of 95 ° C for 20 s, 56 ° C for 30 s and 72 ° C for 1 min, 
followed by 72 ° C for 3 min. Next, the extension primer was de-
signed to hybridize to the amplicon near the SNP site for the ex-
tension of a single or a few bases depending on the allele’s geno-
type. The PCR reactions and PCR product treatment with alka-
line phosphatase and mass extend reactions were all performed 
according to the manufacturer’s (Sequenom) protocol. The final 
base-extension products were later desalted using SpectroClean 
resin (Sequenom), mixed with 3-hydroxypicolinic acid and ana-
lyzed by means of a modified Brucker Autoflex MALDI-TOF 
mass spectrometer (Brucker, Billerica, Mass., USA). 
 Statistical Analysis  
 Statistical differences in allele and genotype frequencies be-
tween the case and control groups were calculated using the   2 -
test or Fisher’s exact test. Meanwhile, the Hardy-Weinberg equi-
librium (HWE) in both groups was performed by the Haploview 
package v4.0  [15] . Afterwards, the linkage disequilibrium (LD) 
blocks were estimated using the Gevalt software V2.0  [16] . The 
LD blocks were defined by Gerbil, an algorithm developed for si-
multaneous phasing of genotypes into haplotypes as well as block 
partitioning  [17, 18] . As for all the analyzed polymorphisms, in-
dividuals with more than 50% missing genotypes were excluded. 
Finally, the haplotype case/control ratios were predicted through 
the Haploview software v3.2  [15] . Since there was a priori evidence 
to support candidacy of each of the SNPs studied, and not all 
markers within genes were independent (i.e. they were in linkage 
disequilibrium), we did not apply a multiple testing correction.
 Results 
 The 14 SNPs tested by Lee et al.  [8] were examined in 
our Chinese data set comprised of 256 AD participants 
and 264 age-matched subjects. All SNPs followed the 
HWE in both the AD and control groups, except 1 SNP 
(rs2532500, HWE p  ! 0.001) which was found to be sig-
nificantly associated with AD as described by Lee et al. 
 [8] . Conversely, the SNPs rs740852 and rs3741924 exhib-
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ited monomorphism in this Chinese data set. Therefore, 
the three SNPs were excluded from subsequent statistical 
analysis. 
 On the other hand, single SNP association analysis 
found two SNPs, rs7311174 (SNP5) and rs2072374 (SNP6), 
as showing nominally significant p values (p = 0.0491 and 
0.0116, respectively,  table 1 ). Of note, the T allele of SNP 
rs7311174 and the C allele of SNP rs2072374 were risk al-
leles (i.e., their presence predisposes to disease develop-
ment). 
 Haplotype analysis was also performed in the 11 SNPs; 
this revealed two LD blocks spanning this region. On the 
one hand, LD block one was found to be significantly as-
sociated with AD, with a global p value of 0.0250. On the 
other hand, LD block two did not show any statistical sig-
nificance. Moreover in LD block one (SNP1–7), haplo-
types CGGATG and CAGTCG demonstrated signifi-
cantly different frequency distributions in the AD and 
control groups. Haplotype CAGTCG showed significant 
uncorrected p = 0.0482, while haplotype CGGATG had 
uncorrected p = 0.0498. As a result, both single marker 
association and haplotype analysis provided evidence 
that the chromosome 12p13 locus was associated with 
AD.
 In line with our previous reports on CYP46A1 and 
ABCA1 using the same Chinese sample pool  [14, 19] , the 
classification of samples into  ApoE   4 allele carrier and 
non-  4 allele carrier groups demonstrated a highly sig-
nificant difference in terms of allele frequency distribu-
tions in both the AD and control groups (OR = 3.86, 95%CI 
2.53–5.88, p  ! 0.0000001). Given that several independent 
groups have reported controversial significance after  ApoE 
  4 allele status stratification  [6–8] , we further analyzed 
the association in  ApoE   4-positive and -negative groups. 
We then determined that SNPs rs7311174 and rs2072374 
continued to be significant (p = 0.0215 and 0.0075) in the 
absence of the  ApoE   4 allele, while another SNP, rs2008134, 
also exhibited significant association (p = 0.0304). How-
ever, no significance could be found for the  ApoE   4-pos-
itive group ( table 1 ). Detailed information of sample strat-
ification by  ApoE   4 allele is listed in online supplemen-
tary table 1 (www.karger.com/doi/10.1159/000 $  $  $ ). 
Meanwhile, haplotype analysis in the  ApoE   4-negative 
group only confirmed haplotype CGGATG association 
with an uncorrected p value of 0.0230 ( table 2 ). 
 Discussion 
 The chromosome 12p13 region was associated with 
late-onset and sporadic AD as evidenced in this Chinese 
data set and as described by Lee et al.  [8] . In their Cauca-
sian data set, Lee et al.  [8] found a strong significance of 
single marker association (SNPs rs2532500 and rs740850). 
Correspondingly, the Chinese data set’s SNPs rs7311174 
and rs2072374 in this region were found to have an asso-
Table 1. Information of genotyped SNPs in a Chinese data set
Mar-
ker
No.
dbSNP rs
No.
Physical
position
Dist. from 
previous 
marker, bp
Gene
name
SNP type Alleles Risk
allele
Minor allele freq. HWE, p value Single marker, p value
cases controls cases controls global APOE
4 +ve
APOE
4 –ve
1 rs2532501 6433014 – TAPBPL NSC(M/V) C/T T 0.244 0.205 0.401 0.788 0.3378 0.2547 0.1343
2 rs2532500 6433071 57 TAPBPL NSC(T/A) C/T – 0.318 0.288 4.659
E-10
3.674
E-8
– – –
3 rs2008134 6458706 25,635 PKP2P1 Intergenic A/G A 0.292 0.375 0.114 0.138 0.0676 0.56 0.0304
4 rs2072373 6502149 43,443 NCAPD2 IN G/A G 0.361 0.388 0.285 0.077 0.5674 0.6396 0.9913
5 rs7311174 6505828 3,679 NCAPD2 IN T/A T 0.258 0.345 0.104 0.309 0.0491 0.515 0.0215
6 rs2072374 6508106 2,278 NCAPD2 SC(R) C/T C 0.267 0.380 0.179 0.729 0.0116 0.7417 0.0075
7 rs740850 6508377 271 NCAPD2 SC(N) G/A A 0.243 0.210 0.163 0.889 0.4091 0.1885 0.1736
8 rs3741916 6514252 5,875 GAPDH 5 UTR C/G C 0.243 0.262 0.142 0.477 0.6773 0.334 0.7845
9 rs3741918 6514517 265 GAPDH IN T/A A 0.406 0.397 0.096 1.000 0.8488 0.8073 0.5814
10 rs1060620 6514983 466 GAPDH IN C/T C 0.461 0.495 0.355 0.577 0.3597 0.6386 0.3952
11 rs1060619 6515042 59 GAPDH IN G/A G 0.457 0.490 0.238 0.648 0.2735 0.5646 0.2831
12 rs740852 6520587 5,545 HOM-
TES-103
IN C/C – 0.0 0.0 1.0 1.0 – – –
13 rs1639122 6581408 60,821 CHD4 NSC(E/D) A/C A 0.466 0.485 1.0 0.734 0.3089 0.4324 0.5856
14 rs3741924 6600217 18,809 GPR92 SC(A) G/G – 0.0 0.0 1.0 1.0 – – –
NSC = Nonsynonymous coding; SC = synonymous coding; IN = intronic.
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ciation. These two significant SNPs also contributed to 
the haplotype association, while allele frequencies in con-
trols of the two significant SNPs were similar to those in 
the Hapmap HCB data set. 
 The LD block prediction and haplotype analysis pro-
vided further evidence that the Chr12p13 region har-
bored a risk locus for AD. Apparently, the LD block con-
struction was different between the Caucasian and Chi-
nese populations. In the Chinese population, two large 
LD blocks across the chromosome 12p13 locus were de-
fined in this report. Conversely, Lee et al. [8] predicted 
three comparatively smaller LD blocks: SNPs1–2 in LD 
block one, SNPs5–6 (or 5–7) in block two, and SNPs10–11 
in block three. 
 The comparatively longer LD block one in the Chinese 
data set encompassed the first two significant blocks 
shown in the study by Lee et al.  [8] . This long LD block 
also included the SNP rs2532500, which did not follow 
the HWE in our Chinese data set, although it was found 
significant in Lee et al.  [8] . Subsequent haplotype asso-
ciation likewise found the two haplotypes, CGGATG and 
CAGTCG, to be associated with AD in the Chinese. It 
was then determined that haplotype CGGATG was a pro-
tective haplotype, while haplotype CAGTCG was its risk-
conferring counterpart. 
 Linkage and linkage disequilibrium studies have 
pointed to several candidate genes on Chr12. Among 
them  A2M ,  GAPDH ,  LRP 1,  GNB 3 and  NCAPD 2 are the 
most frequently studied candidate genes. In Lee et al.  [8] , 
regions surrounding  GAPDH and  NCAPD 2 comprised 
significant signals in both allelic and haplotype associa-
tions and the  NCAPD 2 association was replicated in this 
Chinese study.  NCAPD 2 is short for non-SMC (structur-
al maintenance of chromosomes) condensin I complex, 
subunit D2, and is a chromosome condensation-related 
protein. Previous studies relating chromosome and aging 
have suggested a link between remodeling of chromatin 
structure and aging, which provided one aspect of func-
tional evidence for the genetic linkage  [20, 21] .
 Worth mentioning in association analyses is that ge-
netic heterogeneity is always a factor leading to ambigu-
ous and controversial results. As in chromosome 12 stud-
ies, despite the significant evidence of association shown 
by initial genome screen  [1] and following positive repli-
cations  [4, 5, 22] , Blacker et al.  [23, 24]  by genome scan 
had reported equivocal results from prior published case-
control and familial studies. Their failure to detect a pos-
itive association signal might be due to the mixed sample 
set they used, which was composed of varied family struc-
ture. In addition, the SNP rs3741916 in  GAPDH were 
found to be associated with AD in several Caucasian data 
sets  [7, 8, 25] , although we could not replicate the findings 
in our Chinese population. This may be due to this SNP’s 
insufficient power in the replication data set, or genetic 
heterogeneity among different ethnic groups.
 Particularly with AD association, the  ApoE   4 allele 
plays a critical role due to its strong effect in the AD neu-
ropathological process, therefore generating conflicting 
results in these studies. Indeed, several investigations re-
vealed that in  ApoE   4 allele-positive groups, there is an 
association of the chromosome 12 locus with late-onset 
AD  [5, 8] , while other studies described no confounding 
effect of the  ApoE   4 allele  [6, 7] . In this analysis, we could 
confirm that the chromosome 12 locus associated with 
AD is independent of the  ApoE   4 allele.
 Conclusion 
 The association of chromosome 12p13 multiple loci 
with AD was confirmed in a Chinese data set. Both single 
marker and haplotypic associations were significant. 
Nonetheless, future genetic studies to verify this associa-
tion will need to conduct studies with a larger data set and 
with other ethnic groups. Additionally, a genomewide as-
sociation effort to discover other potentially susceptible 
genetic loci would be of great help to unravel the underly-
ing mechanism of AD development.
 
Table 2. Haplotype distributions in LD block one
Haplotype Case,
CTL freq.
p value APOE 4-negative
case, CTL freq. p value
CAATCG 0.319, 0.303 0.7938 0.343, 0.304 0.4991
CGGATG 0.255, 0.326 0.0497 0.246, 0.348 0.0230
TAGTCA 0.235, 0.202 0.1774 0.247, 0.181 0.0663
CAGTCG 0.134, 0.078 0.0482 0.102, 0.070 0.3398
Global p value   0.025         0.084
CTL = Control; freq. = frequency.
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